Testicular cancer and hormonally active agents

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 11, Issue 3-4, 2008, Pages 260-275

  Garner, Michael ^a   Turner, Michelle C ^a   Ghadirian, Parviz ^b   Krewski, Daniel ^a   Wade, Michael ^c,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HEALTH CANADA   (Canada)

^d Environmental Health Centre Ottawa   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CIGARETTE SMOKING; CORRELATION ANALYSIS; DENMARK; DIET; DISEASE COURSE; EXPERIMENTAL ANIMAL; FETUS DEVELOPMENT; GENETICS; HORMONE ACTION; HUMAN; INCIDENCE; NONHUMAN; OCCUPATIONAL EXPOSURE; PHYSICAL ACTIVITY; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; REVIEW; TESTIS CANCER; TESTIS DISEASE; TESTIS DYSGENESIS SYNDROME;

ANIMALIA;

EID: 41349104483     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937400701873696     Document Type: Review

References (203)

1. Akre, O., Ekbom, A., Hsieh, C. C., Trichopoulos, D., and Adami, H. O. 1996. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J. Natl. Cancer Inst. 88:883-889.
2. Albanes, D. 1987. Total calories, body weight, and tumor incidence in mice. Cancer Res. 47:1987-1992.
3. Armstrong, B., and Doll, R. 1975. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer 15:617-631.
4. Aschim, E. L., Haugen, T. B., Tretli, S., Daltveit, A. K., and Grotmol, T. 2004. Risk factors for hypospadias in Norwegian boys - Association with testicular dysgenesis syndrome? Int. J. Androl. 27:213-221.
5. Auger, J., Kunstmann, J. M., Czyglik, F., and Jouannet, P. 1995. Decline in semen quality among fertile men in Paris during the past 20 years. N. Engl. J. Med. 332:281-285.
6. Auger, J., and Jouannet, P. 1997. Evidence for regional differences of semen quality among fertile French men. Federation Francaise des Centres d'Etude et de Conservation des Oeufs et du Sperme humains. Hum. Reprod. 12:740-745.
7. Berg, J. W. 1996. Cancer epidemiology and prevention. New York: Oxford University Press.
8. Bernstein, L., Depue, R. H., Ross, R. K., Judd, H. L., Pike, M. C., and Henderson, B. E. 1986. Higher maternal levels of free estradiol in first compared to second pregnancy: Early gestational differences. J. Natl. Cancer Inst. 76:1035-1039.
9. Bernstein, L., Pike, M. C., Lobo, R. A., Depue, R. H., Ross, R. K., and Henderson, B. E. 1989. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. Br. J. Obstet. Gynaecol. 96:92-96.
10. Bjorge, T., Tretli, S., Lie, A. K., and Engeland, A. 2006. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes Control 17:983-987.
11. Boisen, K. A., Main, K. M., Rajpert-De Meyts, E., and Skakkebaek, N. E. 2001. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann. NY Acad. Sci. 948:90-99.
12. Bosl, G. J., and Motzer, R. J. 1997. Testicular germ-cell cancer. N. Engl. J. Med. 337:242-253.
13. Bosland, M. C. 1996. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog. Clin. Biol. Res. 394:309-352.
14. Bouskin, A., Nebout, M., Mograbi, B., Brucker-Davis, F., Roger, C., and Fenichel, P. 2008. Estrogens promote human testicular germ cell cancer through a membrane mediated activation of extracellular regulated kinase and protien kinase A. Endoctinology 149:568-573.
15. Bray, F., Richiardi, L., Ekbom, A., Pukkala, E., Cuninkova, M., and Moller H. 2006. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. Int. J. Cancer 118:3099-3111.
16. Bremme, K., Lagerstrom, M., Andersson, O., Johansson, S., and Eneroth, P. 1990. Influences of maternal smoking and fetal sex on maternal serum oestriol, prolactin, hCG, and hPI levels. Arch. Gynecol. Obstet. 247:95-103.
17. Bromen, K., Stang, A., Baumgardt-Elms, C., Stegmaier, C., Ahrens, W., Metz, K. A., and Jockel, K. H. 2004. Testicular, other genital, and breast cancers in first-degree relatives of testicular cancer patients and controls. Cancer Epidemiol. Biomarkers Prev. 13:1316-1324.
18. Brown, L. M., Pottern, L. M., and Hoover, R. N. 1986. Prenatal and perinatal risk factors for testicular cancer. Cancer Res. 46:4812-4816.
19. Brown, L. M., and Pottern, L. M. 1984. Testicular cancer and farming. Lancet 1:1356.
20. Buetow, S. A. 1995. Epidemiology of testicular cancer. Epidemiol. Rev. 17:433-449.
21. Canadian Cancer Society/National Cancer Institute of Canada. 2007. Canadian cancer statistics, 2007. Toronto, Canada.
22. Carlsen, E., Giwercman, A., Keilding, N., and Skakkebaek, N. E. 1992. Evidence for decreasing quality of semen during past 50 years. Br. Med. J. 305:609-618.
23. Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., and Roy, D. 2000. Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 27:75-93.
24. Chia, S. E. 2000. Endocrine disruptors and male reproductive function - A short review. Int. J. Androl. 23(Suppl. 2):45-46.
25. Clemmesen, J. 1997. [Is smoking during pregnancy a cause of testicular cancer?]. Ugeskr. Laeger 159:6815-6819 (Norwegian with English abstract).
26. Coldman, A. J., Elwood, J. M., and Gallagher, R. P. 1982. Sports activities and risk of testicular cancer. Br. J. Cancer 46:749-756.
27. Cook, J. C., Klinefelter, J G. R., Hardisty, F., Sharpe, R. M., and Foster, P. M. 1999. Rodent Leydig cell tumorigenesis: A review of the physiology, pathology, mechanisms, and relevance to humans. Crit. Rev. Toxicol. 29:169-261.
28. Coupland, C. A., Forman, D., Chilvers, C. E., Davey, G., Pike, M. C., and Oliver, R. T. 2004. Maternal risk factors for testicular cancer: A population-based case-control study (UK). Cancer Causes Control 15:277-283.
29. Daston, G. P., Gooch, J. W., Breslin, W. J., Shuey, D. L., Nikiforov, A. I., Fico, T. A., and Gorsuch, J. W. 1997. Environmental estrogens and reproductive health: A discussion of the human and environmental data. Reprod. Toxicol. 11:465-481.
30. Davies, T. W., Palmer, C. R., Ruja, E., and Lipscombe, J. M. 1996. Adolescent milk, dairy product and fruit consumption and testicular cancer. Br. J. Cancer 74:657-660.
31. De Stefani, E., and Ronco, A. L. 1998. Risk factors for testicular cancer: Acase-control study in Uruguay (abstract). 32nd Annual Conference of the International Association of Cancer Registries, PC-5. 8-17-1998. Atlanta, GA.
32. Dearnaley, D. P., Huddart, R. A., and Horwich, A. 2001. Managing testicular cancer. Br. Med. J. 322:1583-1588.
33. Decarli, A., and La Vecchia, C. 1986. Environmental factors and cancer mortality in Italy: Correlational exercise. Oncology 43: 116-126.
34. Delclos, K. B., Bucci, T. J., Lomax, L. G., Latendresse, J. R., Warbritton, A., Weis, C. C., and Newbold, R. R. 2001. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol. 15:647-663.
35. Depue, R. H., Pike, M. C., and Henderson, B. E. 1983. Estrogen exposure during gestation and risk of testicular cancer. J. Natl. Cancer Inst. 71:1151-1155.
36. Dieckmann, K. P., and Pichlmeier, U. 2002. Is risk of testicular cancer related to body size? Eur. Urol. 42:564-569.
37. Dieckmann, K. P., and Pichlmeier, U. 2004. Clinical epidemiology of testicular germ cell tumors. World J. Urol. 22:2-14.
38. Dieckmann, K. P., Endsin, G., and Pichlmeier, U. 2001. How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur. Urol. 40:677-683.
39. English, P. B., Goldberg, D. E., Wolff, C., and Smith, D. 2003. Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control 14:815-825.
40. Fisher, J. S., Macpherson, S., Marchetti, N., and Sharpe, R. M. 2003. Human 'testicular dysgenesis syndrome': A possible model using in-utero exposure of the rat to dibutyl phthalate. Hum. Reprod. 18:1383-1394.
41. Fleming, L. E., Bean, J. A., Rudolph, M., and Hamilton, K. 1999. Cancer incidence in a cohort of licensed pesticide applicators in Florida. J. Occup. Environ. Med. 41:279-288.
42. Gallagher, R. P., Huchcroft, S., Hill, G., and Phillips, N. 1994 Physical activity and dietary factors in testicular cancer (abstr.). Epidemiology 108:S27.
43. Gallagher, R. P., Huchcroft, S., Phillips, N., Hill, G. B., Coldman, A. J., Coppin, C., and Lee, T. 1995. Physical activity, medical history, and risk of testicular cancer (Alberta and British Columbia, Canada). Cancer Causes Control 6:398-406.
44. Ganmaa, D., Li, X. M., Wang, J., Qin, L. Q., Wang, P. Y., and Sato, A. 2002. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int. J. Cancer 98:262-267.
45. Garner, M. J., Birkett, N. J., Johnson, K. C., Shatenstein, B., Ghadirian, P., and Krewski, D. 2003. Dietary risk factors for testicular carcinoma. Int. J. Cancer 106:934-941.
46. Geary, M. P., Pringle, P. J., Rodeck, C. H., Kingdom, J. C., and Hindmarsh, P. C. 2003. Sexual dimorphism in the growth hormone and insulin-like growth factor axis at birth 10. J. Clin. Endocrinol. Metab. 88:3708-3714.
47. Gill, W. B., Schumacher, G. F., and Bibbo, M. 1977. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. J. Urol. 117:477-480.
48. Gill, W. B., Schumacher, G. F., Bibbo, M., Straus, F. H., and Schoenberg, H. W. 1979. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J. Urol. 122:36-39.
49. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., and Willett, W. C. 1993. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85:1571-1579.
50. Giwercman, A., Muller, J., and Skakkeboek, N. E. 1988. Cryptorchidism and testicular neoplasia. Horm. Res. 30:157-163.
51. Graham, S., Gibson, R., West, D., Swanson, M., Burnett, W., and Dayal, H. 1977. Epidemiology of cancer of the testis in upstate New York. J. Natl. Cancer Inst. 58:1255-1261.
52. Gray, L. E., Ostby, J., Furr, J., Price, M., Veeramachaneni, D. N., and Parks, L. 2000. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol. Sci. 58:350-365.
53. Gray, L. E., Jr., Kelce, W. R., Monosson, E., Ostby, J. S., and Birnbaum, L. S. 1995. Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: Reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol. Appl. Pharmacol.131:108-118.
54. Gray, L. E., Jr., Wolf, C., Lambright, C., Mann, P., Price, M., Cooper, R. L., and Ostby, J. 1999. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexylphthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol. Ind. Health 15:94-118.
55. Grigor, K. M. 1993. A new classification of germ cell tumours of the testis. Eur. Urol. 23:93-100.
56. Gundy, S., Babosa, M., Baki, M., and Bodrogi, I. 2004. Increased predisposition to cancer in brothers and offspring of testicular tumor patients. Pathol. Oncol. Res. 10:197-203.
57. Hardell, L., Nasman, A., Ohlson, C. G., and Fredrikson, M. 1998. Case-control study on risk factors for testicular cancer. Int. J. Oncol. 13:1299-1303.
58. Hardell, L., van Bavel, B., Lindstrom, G., Carlberg, M., Dreifaldt, A. C., Wijkstrom, H., Starkhammar, H., Eriksson, M., Hallquist, A., and Kolmert, T. 2003. Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ. Health Perspect. 111:930-934.
59. Hardell, L., Bavel, B., Lindstrom, G., Eriksson, M., and Carlberg, M. 2006. In utero exposure to persistent organic pollutants in relation to testicular cancer risk. Int. J. Androl. 29:228-234.
60. Harland, S. J., Cook, P. A., Fossa, S. D., Horwich, A., Mead, G. M., Parkinson, M. C., Roberts, J. T., and Stenning, S. P. 1998. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: Defining a high risk group. J. Urol. 160:1353-1357.
61. Hartley, A. L., Birch, J. M., Kelsey, A. M., Marsden, H. B., Harris, M., and Teare, M. D. 1989. Are germ cell tumors part of the Li-Fraumeni cancer family syndrome? Cancer Genet. Cytogenet. 42:221-226.
62. Hartmann, S., Lacorn, M., and Steinhart, H. 1998. Natural occurrence of steroid hormones in food. Food Chem. 62:7-20.
63. Haughey, B. P., Graham, S., Brasure, J., Zielezny, M., Sufrin, G., and Burnett, W. S. 1989. The epidemiology of testicular cancer in upstate New York. Am. J. Epidemiol. 130:25-36.
64. Hayes, R. B., Brown, L. M., Pottern, L. M., Gomez, M., Kardaun, J. W., Hoover, R. N., O'Connell, K. J., Sutzman, R. E., and Javadpour, N. 1990. Occupation and risk for testicular cancer: A case-control study. Int. J. Epidemiol. 19:825-831.
65. Hemminki, K., and Li, X. 2004. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br. J. Cancer 90:1765-1770.
66. Henderson, B. E., Benton, B., Jing, J., Yu, M. C., and Pike, M. C. 1979. Risk factors for cancer of the testis in young men. Int. J. Cancer 23:598-602.
67. Higuchi, T. T., Palmer, J. S., Gray, L. E., Jr., and Veeramachaneni, D. N. 2003. Effects of dibutyl phthalate in male rabbits following in utero, adolescent, or postpubertal exposure. Toxicol. Sci. 72:301-313.
68. Hoei-Hansen, C. E., Rajpert-De Meyts, E., Daugaard, G., and Skakkebaek, N. E. 2005. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: A clinical review. Ann. Oncol. 16:863-868.
69. Huyghe, E., Matsuda, T., and Thonneau, P. 2003. Increasing incidence of testicular cancer worldwide: A review. J. Urol. 170:5-11.
70. Jacobsen, R., Bostofte, E., Engholm, G., Hansen, J., Olsen, J. H., Skakkebaek, N. E., and Moller, H. 2000. Risk of testicular cancer in men with abnormal semen characteristics: Cohort study. Br. Med. J. 321:789-792.
71. Jensen, M. S., Mabeck, L. M., Toft, G., Thulstrup, A. M., and Bonde, J. P. 2005. Lower sperm counts following prenatal tobacco exposure. Hum. Reprod. 20:2559-2566.
72. Jensen, O. M., Olsen, J. H., and Osterlind, A. 1984. Testis cancer risk among farmers in Denmark. Lancet 1:794.
73. Jensen, T. K., Jorgensen, N., Punab, M., Haugen, T. B., Suominen, J., Zilaitiene, B., Horte, A., Andersen, A. G., Carlsen, E., Magnus, O., Matulevicius, V., Nermoen, I., Vierula, M., Keiding, N., Toppari, J., and Skakkebaek, N. E. 2004. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: A cross-sectional study of 1,770 young men from the general population in five European countries. Am. J. Epidemiol. 159:49-58.
74. Jensen, T. K., Toppari, J., Keiding, N., and Skakkebaek, N. E. 1995. Do environmental estrogens contribute to the decline in male reproductive health? Clin. Chem. 41:1896-1901.
75. Jiang, L. I., and Nadeau, J. H. 2001. 129/Sv mice - A model system for studying germ cell biology and testicular cancer. Mamm. Genome 12:89-94.
76. Joffe, M. 2001. Are problems with male reproductive health caused by endocrine disruption? Occup. Environ. Med. 58:281-287.
77. John Radcliffe Hospital Cryptorchidism Study Group. 1986. Cryptorchidism: An apparent substantial increase since 1960. John Radcliffe Hospital Cryptorchidism Study Group. Br. Med. J. (Clin. Res. Ed.) 293:1401-1404.
78. Jorgensen, N., Andersen, A. G., Eustache, F., Irvine, D. S., Suominen, J., Petersen, J. H., Andersen, A. N., Auger, J., Cawood, E. H., Horte, A., Jensen, T. K., Jouannet, P., Keiding, N., Vierula, M., Toppari, J., and Skakkebaek, N. E. 2001. Regional differences in semen quality in Europe. Hum. Reprod. 16:1012-1019.
79. Jorgensen, N., Asklund, C., Carlsen, E., and Skakkebaek, N. E. 2006. Coordinated European investigations of semen quality: Results from studies of Scandinavian young men is a matter of concern. Int. J. Androl. 29:54-61.
80. Kaijser, M., Granath, F., Jacobsen, G., Cnattingius, S., and Ekbom, A. 2000. Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data 99. Epidemiology 11:315-319.
81. Kanto, S., Hiramatsu, M., Suzuki, K., Ishidoya, S., Saito, H., Yamada, S., Satoh, M., Saito, S., Fukuzaki, A., and Arai, Y. 2004. Risk factors in past histories and familial episodes related to development of testicular germ cell tumor. Int. J. Urol. 11:640-646.
82. Key, T. J., Bull, D., Ansell, P., Brett, A. R., Clark, G. M., Moore, J. W., Chilvers, C. E., and Pike, M. C.1996. A case-control study of cryptorchidism and maternal hormone concentrations in early pregnancy. Br. J. Cancer 73:698-701.
83. Kim, H. S., Kim, T. S., Shin, J.-H., Moon, H. J. Kang, I. H., Kim, I. Y. Oh, J. Y., and Han, S. Y. 2004. Neonatal exposure to di(n-butyl)- phthalate alters male reproductive tract development. J. Toxicol. Environ. Health A 67:2045-2060.
84. Kliesch, S., Bergmann, M., Hertle, L., Nieschlag, E., and Behre, H. M. 1997. Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum. Reprod. 12:2830-2835.
85. Klotz, L. H. 1999. Why is the rate of testicular cancer increasing? [editorial; comment]. Can Med. Assoc. J. 160:213-214.
86. Knight, J. A., Marrett, L. D., and Weir, H. K. 1996. Occupation and risk of germ cell testicular cancer by histologic type in Ontario. J. Occup. Environ. Med. 38:884-890.
87. Kristensen, P., Andersen, A., Irgens, L. M., Bye, A. S., and Vagstad, N. 1996. Testicular cancer and parental use of fertilizers in agriculture. Cancer Epidemiol. Biomarkers Prev. 5:3-9.
88. Kwack, S.-J., Kimm, S. S., Choi, Y. W., Rhee, G. S., Lee, R. D., Seok, J. H., Chae, S. Y., Won, Y. H., Lim, K. J., Choi, K. S., Park, K. L., and Lee, B. M. 2004. Mechanism of antifertility in male rats treated with 3-monochloro-1,2-propanediol (3-MCPD). J. Toxicol. Environ. Health A 67:2001-2011.
89. Langer, B., Dorsch, M., Gartner, K., Wedekind, D., Kamino, K., and Hedrich, H. J. 2004. WKY/Ztm-ter: A new rat inbred strain on the WKY/Ztm genetic background with congenital teratomas. Lab. Anim. 38:425-431.
90. Leary, F. J., Resseguie, L. J., Kurland, L. T., O'Brien, P. C., Emslander, R. F., and Noller, K. L. 1984. Males exposed in utero to diethylstilbestrol. J. Am. Med. Assoc. 252:2984-2989.
91. LeMasters, G. K., Genaidy, A. M., Succop, P., Deddens, J., Sobeih, T., Barriera-Viruet, H., Dunning, K., and Lockey, J. 2006. Cancer risk among firefighters: A review and meta-analysis of 32 studies. J. Occup. Environ. Med. 48:1189-1202.
92. Liu, S., Wen, S. W., Mao, Y., Mery, L., and Rouleau, J. 1999. Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can. J. Public Health 90:176-180.
93. Mably, T. A., Bjerke, D. J., Moore, R. W., Gendron-Fitzpatrick, A., and Peterson, R. E. 1992. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects on spermatogenesis and reproductive capability. Toxicol. Appl. Pharmacol. 114:118-126.
94. Main, K. M., Mortensen, G. K., Kaleva, M. M., Boisen, K. A., Damgaard, I. N., Chellakooty, M., Schmidt, I. M., Suomi, A. M., Virtanen, H. E., Petersen, D. V., Andersson, A. M., Toppari, J., and Skakkebaek, N. E. 2006. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ. Health Perspect. 114:270-276.
95. Marsee, K., Woodruff, T. J., Axelrad, D. A., Calafat, A. M., and Swan, S. H. 2006. Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance. Environ. Health Perspect. 114:805-809.
96. Marshall, E. G., Melius, J. M., London, M. A., Nasca, P. C., and Burnett, W. S. 1990. Investigation of a testicular cancer cluster using a case-control approach. Int. J. Epidemiol. 19:269-273.
97. Martin, O. V., Shialis, T., Lester, J. N., Scrimshaw, M. D., Boobis, A. R., and Voulvolulis, N. 2008. Testicular dysgenesis syndrome and the estrogen hypothesis: A quantitative Meta-alalysis . Envir Health Prespect. 116:149-157.
98. McDowall, M., and Balarajan, R. 1984. Testicular cancer and employment in agriculture. Lancet 1:510-511.
99. McEwen, G. N., Jr., and Renner, G. 2006. Validity of anogenital distance as a marker of in utero phthalate exposure. Environ. Health Perspect. 114:A19-A20.
100. McGlynn, K. A., Zhang, Y., Sakoda, L. C., Rubertone, M. V., Erickson, R. L., and Graubard, B. I. 2006. Maternal smoking and testicular germ cell tumors. Cancer Epidemiol. Biomarkers Prev. 15:1820-1824.
101. McGlynn, K. A., Sakoda, L. C., Rubertone, M. V., Sesterhenn, I. A., Lyu, C., Graubard, B. I., and Erickson, R. L. 2007. Body size, dairy consumption, puberty, and risk of testicular germ cell tumors. Am. J. Epidemiol. 165:355-363.
102. Mills, P. K., Newell, G. R., and Johnson, D. E. 1984. Testicular cancer associated with employment in agriculture and oil and natural gas extraction. Lancet 1:207-210.
103. Moller, H. 1993. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur. Urol. 23:8-13.
104. Moller, H. 1997. Work in agriculture, childhood residence, nitrate exposure, and testicular cancer risk: A case-control study in Denmark. Cancer Epidemiol. Biomarkers Prev. 6:141-144.
105. Moller, H. 1998. Trends in sex-ratio, testicular cancer and male reproductive hazards: Are they connected? APMIS 106:232-238.
106. Moller, H., and Skakkebaek, N. E. 1996. Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: Case-control studies in Denmark. Int. J. Cancer 66:287-293.
107. Moller, H., and Skakkebaek, N. E. 1997. Testicular cancer and cryptorchidism in relation to prenatal factors: Case-control studies in Denmark. Cancer Causes Control 8:904-912.
108. Moller, H., and Skakkebaek, N. E. 1999. Risk of testicular cancer in subfertile men: Case-control study. Br. Med. J. 318:559-562.
109. Moller, H., Prener, A., and Skakkebaek, N. E. 1996. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: Case-control studies in Denmark. Cancer Causes Control 7:264-274.
110. Moller, H., Cortes, D., Engholm, G., and Thorup, J. 1998. Risk of testicular cancer with cryptorchidism and with testicular biopsy: Cohort study. Br. Med. J. 317:729.
111. Mori, M., Davies, T. W., Miyake, H., Masuoka, H., Kumamoto, Y., and Tsukamoto, T. 1990. Maternal factors of testicular cancer: A case-control study in Japan. Jpn. J. Clin. Oncol. 20:72-77.
112. Moss, A. R., Osmond, D., Bacchetti, P., Torti, F. M., and Gurgin, V. 1986. Hormonal risk factors in testicular cancer. A case-control study. Am. J. Epidemiol. 124:39-52.
113. Muir, C., Waterhouse, J., Mack, T., Powell, J., and Whelan, S. 1987. Cancer incidence in five continents. Lyon: International Agency for Research on Cancer, 1987.
114. Murty, V. V., and Chaganti, R. S. 1998. A genetic perspective of male germ cell tumors. Semin. Oncol. 25:133-144.
115. Mylchreest, E., Sar, M., Cattley, R. C., and Foster, P. M. 1999. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol. Appl. Pharmacol. 156:81-95.
116. Newbold, R. R., Bullock, B. C., and McLachlan, J. A. 1985. Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol. Cancer Res. 45:5145-5150.
117. Newbold, R. R., Bullock, B. C., and McLachlan, J. A. 1987. Testicular tumors in mice exposed in utero to diethylstilbestrol. J. Urol. 138:1446-1450.
118. Nicholson, P. W., and Harland, S. J. 1995. Inheritance and testicular cancer. Br. J. Cancer 71:421-426.
119. Noguchi, T., and Noguchi, M. 1985. A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J. Natl. Cancer Inst. 75:385-392.
120. Oliver, R. T., and Oliver, J. C. 1996. Endocrine hypothesis for declining sperm count and rising incidence of cancer. Lancet 347: 339-340.
121. Oosterhuis, J. W., and Looijenga, L. H. 2003. Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: Highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis. APMIS 111: 280-289.
122. Panagiotopoulou, K., Katsouyanni, K., Petridou, E., Garas, Y., Tzonou, A., and Trichopoulos, D. 1990. Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1:119-124.
123. Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L., and Young, J. 1997. Cancer incidence in five continents, Vol. VII. 143. 1-1-1997. Lyon: IARC Scientific Publications.
124. Parks, L. G., Ostby, J. S., Lambright, C. R., Abbott, B. D., Klinefelter, G. R., Barlow, N. J., and Gray, L. E., Jr. 2000. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol. Sci. 58:339-349.
125. Paulozzi, L. J., Erickson, J. D., and Jackson, R. J. 1997. Hypospadias trends in two US surveillance systems. Pediatrics 100:831-834.
126. Paulozzi, L. J. 1999. International trends in rates of hypospadias and cryptorchidism. Environ. Health Perspect. 107:297-302.
127. Pesce, M., Farrace, M. G., Piacentini, M., Dolci, S., and De Felici, M. 1993. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 118:1089-1094.
128. Petersen, P. M., Giwercman, A., Hansen, S. W., Berthelsen, J. G., Daugaard, G., Rorth, M., and Skakkebaek, N. E. 1999. Impaired testicular function in patients with carcinoma-in-situ of the testis. J. Clin. Oncol. 17:173-179.
129. Petridou, E., Panagiotopoulou, K., Katsouyanni, K., Spanos, E., and Trichopoulos, D. 1990. Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1:247-250.
130. Petridou, E., Roukas, K. I., Dessypris, N., Aravantinos, G., Bafaloukos, D., Efraimidis, A., Papacharalambous, A., Pektasidis, D., Rigatos, G., and Trichopoulos, D. 1997. Baldness and other correlates of sex hormones in relation to testicular cancer. Int. J. Cancer 71:982-985.
131. Prener, A., Hsieh, C. C., Engholm, G., Trichopoulos, D., and Jensen, O. M. 1992. Birth order and risk of testicular cancer. Cancer Causes Control 3:265-272.
132. Punab, M., Zilaitiene, B., Jorgensen, N., Horte, A., Matulevicius, V., Peetsalu, A., and Skakkebaek, N. E. 2002. Regional differences in semen qualities in the Baltic region. Int. J. Androl 25:243-252.
133. Rapley, E. A., Crockford, G. P., Teare, D., Biggs, P., Seal, S., Barfoot, R., Edwards, S., Hamoudi, R., Heimdal, K., Fossâ, S. D., Tucker, K., Donald, J., Collins, F., Friedlander, M., Hogg, D., Goss, P., Heidenreich, A., Ormiston, W., Daly, P. A., Forman, D., Oliver, T. D., Leahy, M., Huddart, R., Cooper, C. S., Bodmer, J. G., Easton, D. F., Stratton, M. R., and Bishop, D. T. 2000. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat. Genet. 24:197-200.
134. Rhomberg, W., Schmoll, H. J., and Schneider, B. 1995. High frequency of metalworkers among patients with seminomatous tumors of the testis: A case-control study. Am. J. Ind. Med. 28:79-87.
135. Richiardi, L., Akre, O., Bellocco, R., and Ekbom, A. 2002. Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br. J. Cancer 87:545-550.
136. Richiardi, L., Akre, O., Lambe, M., Granath, F., Montgomery, S. M., and Ekbom, A. 2004a. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 15:323-329.
137. Richiardi, L., Akre, O., Montgomery, S. M., Lambe, M., Kvist, U., and Ekbom, A.2004.b Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J. Natl. Cancer Inst. 96:145-147.
138. Risch, H. A., Jain, M., Marrett, L. D., and Howe, G. R. 1994. Dietary fat intake and risk of epithelial ovarian cancer. J. Natl. Cancer Inst. 86:1409-1415.
139. Rorth, M., Rajpert-De Meyts, E., Andersson, L., Dieckmann, K. P., Fossa, S. D., Grigor, K. M., Hendry, W. F., Herr, H. W., Looijenga, L. H., Oosterhuis, J. W., and Skakkebaek, N. E. 2000. Carcinoma in situ in the testis. Scand. J. Urol. Nephrol. Suppl. 205:166-186.
140. Ross, R. K., McCurtis, J. W., Henderson, B. E., Menck, H. R., Mack, T. M., and Martin, S. P. 1979. Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br. J. Cancer 39:284-292.
141. Sabroe, S., and Olsen, J. 1998. Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: A case-cohort study based on midwives' records in Denmark. Int. J. Cancer 78:140-143.
142. Sewell, C. M., Castle, S. P., Hull, H. F., and Wiggins, C. 1986. Testicular cancer and employment in agriculture and oil and natural gas extraction. Lancet 1:553.
143. Sharpe, R. M. 1993. Declining sperm counts in men - Is there an endocrine cause? J. Endocrinol. 136:357-360.
144. Sharpe, R. M., and Skakkebaek, N. E. 1993. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395.
145. Sharpe, R. M. 2003. The 'oestrogen hypothesis '- Where do we stand now? Int. J. Androl. 26:2-15.
146. Sheinfeld, J. 1994. Nonseminomatous germ cell tumors of the testis: current concepts and controversies. Urology 44:2-14.
147. Shin, J.-H., Kim, H. S., Moon, H. J., Kang, I. H., Kim, T. S., Seok, J. H., Kim, I. Y., Park, K. L., Han, S. Y., and Nam, S. Y. 2002. Effects of flutamide on puberty in male rats: An evaluation of the protocol for the assessment of pubertal development and thyroid function. J. Toxicol. Environ. Health A 65: 433-445.
148. Sigurdson, A. J., Chang, S., Annegers, J. F., Duphorne, C. M., Pillow, P. C., Amato, R. J., Hutchinson, L. P., Sweeney, A. M., and Strom, S. S. 1999. A case-control study of diet and testicular carcinoma. Nutr. Cancer 34:20-26.
149. Skakkebaek, N. E., Berthelsen, J. G., and Muller, J. 1982. Carcinoma-in-situ of the undescended testis. Urol. Clin. North Am. 9:377-385.
150. Skakkebaek, N. E., Rajpert-De Meyts, E., and Main, K. M. 2001. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16:972-978.
151. Skakkebaek, N. E., Holm, M., Hoei-Hansen, C., Jorgensen, N., and Rajpert-De Meyts, E. 2003. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: Evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS 111:1-9.
152. Spermon, J. R., Witjes, J. A., Nap, M., and Kiemeney, L. A. 2001. Cancer incidence in relatives of patients with testicular cancer in the eastern part of The Netherlands. Urology 57:747-752.
153. Srivastava, A., and Kreiger, N. 2000. Relation of physical activity to risk of testicular cancer. Am. J. Epidemiol. 151:78-87.
154. Srivastava, A., and Kreiger, N. 2004. Cigarette smoking and testicular cancer. Cancer Epidemiol. Biomarkers Prev. 13:49-54.
155. Stang, A., Ahrens, W., Baumgardt-Elms, C., Stegmaier, C., Merzenich, H., de Vrese, M., Schrezenmeir, J., and Jockel, K. H. 2006. Adolescent milk fat and galactose consumption and testicular germ cell cancer. Cancer Epidemiol. Biomarkers Prev. 15:2189-2195.
156. Starr, J. R., Chen, C., Doody, D. R., Hsu, L., Ricks, S., Weiss, N. S., and Schwartz, S. M. 2005. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiol. Biomarkers Prev. 14:2183-2190.
157. Stevens, L. C., and Hummel, K. P. 1957. A description of spontaneous congenital testicular teratomas in strain 129 mice. J. Natl. Cancer Inst. 18:719-747.
158. Stevens, L. C. 1962. Testicular teratomas in fetal mice. J. Natl. Cancer Inst. 28:247-267.
159. Stevens, L. C. 1967a Origin of testicular teratomas from primordial germ cells in mice. J. Natl. Cancer Inst. 38:549-552.
160. Stevens, L. C. 1967b. The biology of teratomas. Adv. Morphol. 6:1-31.
161. Storgaard, L., Bonde, J. P., Ernst, E., Spano, M., Andersen, C. Y., Frydenberg, M., and Olsen, J. 2003. Does smoking during pregnancy affect sons' sperm counts? Epidemiology 14:278-286.
162. Storgaard, L., Bonde, J. P., and Olsen, J. 2006. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod. Toxicol. 21:4-15.
163. Strohsnitter, W. C., Noller, K. L., Hoover, R. N., Robboy, S. J., Palmer, J. R., Titus-Ernstoff, L., Kaufman, R. H., Adam, E., Herbst, A. L., and Hatch, E. E. 2001. Cancer risk in men exposed in utero to diethylstilbestrol. J. Natl. Cancer Inst. 93:545-551.
164. Swan, S. H., Elkin, E. P., and Fenster, L. 1997. Have sperm densities declined? A reanalysis of global trend data. Environ. Health Perspect. 105:1228-1232.
165. Swan, S. H., Brazil, C., Drobnis, E. Z., Liu, F., Kruse, R. L., Hatch, M., Redmon, J. B., Wang, C., Overstreet, J. W., and The Study For Future Families Research Group. 2003. Geographic differences in semen quality of fertile U.S. males. Environ. Health Perspect. 111:414-420.
166. Swan, S. H., Main, K. M., Liu, F., Stewart, S. L., Kruse, R. L., Calafat, A. M., Mao, C. S., Redmon, J. B., Ternand, C. L., Sullivan, S., and Teague, J. L. 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113:1056-1061.
167. Swan, S. H. 2006. Prenatal phthalate exposure and anogenital distance in male infants. Environ. Health Perspect. 114:A88-A89.
168. Swerdlow, A. J., and Skeet, R. G. 1988. Occupational associations of testicular cancer in south east England. Br. J. Ind. Med. 45:225-230.
169. Swerdlow, A. J., Huttly, S. R., and Smith, P. G. 1987. Prenatal and familial associations of testicular cancer. Br. J Cancer 55:571-577.
170. Swerdlow, A. J., Huttly, S. R., and Smith, P. G. 1989. Testis cancer: Post-natal hormonal factors, sexual behaviour and fertility. Int. J. Cancer 43:549-553.
171. Swerdlow, A. J., De Stavola, B. L., Swanwick, M. A., and Maconochie, N. E. 1997. Risks of breast and testicular cancers in young adult twins in England and Wales: Evidence on prenatal and genetic aetiology. Lancet 350:1723-1728.
172. Swerdlow, A. J., De Stavola, B. L., Swanwick, M. A., Mangtani, P., and Maconochie, N. E. 1999. Risk factors for testicular cancer: A case-control study in twins. Br. J. Cancer 80:1098-1102.
173. Takabayashi, S., Sasaoka, Y., Yamashita, M., Tokumoto, T., Ishikawa, K., and Noguchi, M. 2001. Novel growth factor supporting survival of murine primordial germ cells: Evidence from conditioned medium of ter fetal gonadal somatic cells. Mol. Reprod. Dev. 60:384-396.
174. Tarone, R. E., Hayes, H. M., Hoover, R. N., Rosenthal, J. F., Brown, L. M., Pottern, L. M., Javadpour, N., O'Connell, K. J., and Stutzman, R. E. 1991. Service in Vietnam and risk of testicular cancer. J. Natl. Cancer Inst. 83:1497-1499.
175. Tennekes, H., Kaufmann, W., Dammann, M., and van Ravenzwaay, B. 2004. The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment. Regul. Toxicol. Pharmacol. 40:293-304.
176. Thune, I., and Lund, E. 1994. Physical activity and the risk of prostate and testicular cancer: A cohort study of 53,000 Norwegian men. Cancer Causes Control 5:549-556.
177. Toft, G., Axmon, A., Giwercman, A., Thulstrup, A. M., Rignell-Hydbom, A., Pedersen, H. S., Ludwicki, J. K., Zvyezday, V., Zinchuk, A., Spano, M., Manicardi, G. C., Bonefeld-Jorgensen, E. C., Hagmar, L., and Bonde, J. P. 2005. Fertility in four regions spanning large contrasts in serum levels of widespread persistent organochlorines: A cross-sectional study. Environ. Health 4:26.
178. Toppari, J., Larsen, J. C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L. J., Jr., Jegou, B., Jensen, T. K., Jouannet, P., Keiding, N., Leffers, H., McLachlan, J. A., Meyer, O., Muller, J., Rajpert-De Meyts, E., Scheike, T., Sharpe, R., Sumpter, J., and Skakkebaek, N. E. 1996. Male reproductive health and environmental xenoestrogens. Environ. Health Perspect. 104(Suppl. 4):741-803.
179. UKTCSG. 1994a. Social, behavioural and medical factors in the aetiology of testicular cancer: Results from the UK study. UK Testicular Cancer Study Group. Br. J. Cancer 70:513-520.
180. UKTCSG. 1994b. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group. Br. Med. J. 308:1393-1399.
181. Uzumcu, M., Suzuki, H., and Skinner, M. K. 2004. Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod. Toxicol. 18:765-774.
182. Van den Eeden, S. K., Weiss, N. S., Strader, C. H., and Daling, J. R. 1991. Occupation and the occurrence of testicular cancer. Am. J. Ind. Med. 19:327-337.
183. Veeramachaneni, D. N., and Vandewoude, S. 1999. Interstitial cell tumour and germ cell tumour with carcinoma in situ in rabbit testes. Int. J .Androl. 22:97-101.
184. Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., and Bowers, C. Y. 2005. Endocrine control of body composition in infancy, childhood, and puberty. Endocr. Rev. 26:114-146.
185. Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., and Bowers, C. Y. 2006. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr. Rev. 27:101-140.
186. Walcott, F. L., Hauptmann, M., Duphorne, C. M., Pillow, P. C., Strom, S. S., and Sigurdson, A. J. 2002. A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr. Cancer 44:44-51.
187. Walker, A. H., Bernstein, L., Warren, D. W., Warner, N. E., Zheng, X., and Henderson, B. E. 1990. The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice. Br. J. Cancer 62:599-602.
188. Wanderas, E. H., Tretli, S., and Fossa, S. D. 1995. Trends in incidence of testicular cancer in Norway 1955-1992. Eur. J. Cancer 31A:2044-2048.
189. Wanderas, E. H., Grotmol, T., Fossa, S. D., and Tretli, S. 1998. Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: A prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9:475-486.
190. Weir, H. K., Kreiger, N., and Marrett, L. D. 1998. Age at puberty and risk of testicular germ cell cancer (Ontario, Canada). Cancer Causes Control 9:253-258.
191. Weir, H. K., Marrett, L. D., Kreiger, N., Darlington, G. A., and Sugar, L. 2000. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int. J. Cancer 87:438-443.
192. Westergaard, T., Olsen, J. H., Frisch, M., Kroman, N., Nielsen, J. W., and Melbye, M. 1996. Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study Int. J. Cancer 66:627-631.
193. Westergaard, T., Andersen, P. K., Pedersen, J. B., Frisch, M., Olsen, J. H., and Melbye, M. 1998. Testicular cancer risk and maternal parity: A population-based cohort study. Br. J. Cancer 77:1180-1185.
194. Whittemore, A. S., Wu-Williams, A. H., Lee, M., Zheng, S., Gallagher, R. P., Jiao, D. A., Zhou, L., Wang, X. H., Chen, K., and Jung, D. 1990. Diet, physical activity, and colorectal cancer among Chinese in North America and China. J. Natl. Cancer Inst. 82:915-926.
195. Wilcox, A. J., Baird, D. D., Weinberg, C. R., Hornsby, P. P., and Herbst, A. L. 1995. Fertility in men exposed prenatally to diethylstilbestrol. N. Engl. J. Med. 332:1411-1416.
196. Wilcox, M. A., Chang, A. M., and Johnson. I. R. 1996. The effects of parity on birthweight using successive pregnancies. Acta Obstet. Gynecol. Scand. 75:459-3.
197. Willett, W. 1998. Nutritional epidemiology. New York: Oxford University Press.
198. Yasuda, Y., Kihara, T., and Tanimura. T. 1985. Effect of ethinyl estradiol on the differentiation of mouse fetal testis. Teratology 32:113-118.
199. Yasuda, Y., Konishi, H., and Tanimura, T. 1986. Leydig cell hyperplasia in fetal mice treated transplacentally with ethinyl estradiol. Teratology 33:281-288.
200. Yasuda, Y., Ohara, I., Konishi, H., and Tanimura, T. 1988. Long-term effects on male reproductive organs of prenatal exposure to ethinyl estradiol. Am. J. Obstet. Gynecol. 159:1246-1250.
201. Youngren, K. K., Coveney, D., Peng, X., Bhattacharya, C., Schmidt, L. S., Nickerson, M. L., Lamb, B. T., Deng, J. M., Behringer, R. R., Capel, B., Rubin, E. M.,. Nadeau, J. H, and Matin, A. 2005. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435:360-364.
202. Yue, W., Santen, R. J., Wang, J. P., Li, Y., Verderame, M. F., Bocchinfuso, W. P., Korach, K. S., Devanesan, P., Todorovic, R., Rogan, E. G., and Cavalieri,, E. L. 2003. Genotoxic metabolites of estradiol in breast: Potential mechanism of estradiol induced carcinogenesis. J. Steroid Biochem. Mol. Biol. 86:477-486.
203. Zheng, T., Holford, T. R., Ma, Z., Ward, B. A., Flannery, J., and Boyle, P. 1996. Continuing increase in incidence of germ-cell testis cancer in young adults: Experience from Connecticut, USA, 1935-1992. Int. J. Cancer 65:723-729.